Global Expansion: Urgent Strategies for Taiwan Biotech to Thrive Beyond Borders

Taiwan pharmaceutical market size is only less 1% of global pharmaceutical market, thus, Taiwan biotech company must enter global Market, otherwise the company growth will be very limited.

So either Taiwan R&D or generics company must think about how to be player in the global market. And the first issue is market intelligence, which is one of weakness for Taiwan.

Local market intelligence should include political and economic situation, healthcare policy, healthcare system, regulatory, medical and drug reimbursement schemes etc.

So how to build up infrastructure and know how of international business development is a crucial and urgent item.